Manlangit, Baby Boy .

HRN: 22-13-54  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2022
AMPICILLIN 500MG (VIAL)
10/31/2022
11/07/2022
IV
170 Mg
Q12
PSNB, Hep B Reactive Mother
Waiting Final Action 
10/31/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
10/31/2022
11/07/2022
IV
17 Mg
Q24
PSNB; Hep B Reactive Mother
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: